Albert M. Bernath

1.6k citations

39 papers · 1.1k indexed · h-index 18

Impact in

Applied Psychology top 5%
- Behavioral Health and Interventions
Oncology top 5%
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Oncology 24
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 7
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 6
Applied Psychology 3

Co-authors: Kendrith M. Rowland Loren K. Tschetter Robert C. Kane Edith A. Perez David D. Beiler Elisa Martinez Daron Ferris Patrick Reynolds
Journals: Journal of Clinical Oncology (10 papers)Cancer (5 papers)Addictive Behaviors (3 papers)Clinical Breast Cancer (2 papers)Mayo Clinic Proceedings (2 papers)
Partner nations: United States India Canada

In The Last Decade

Albert M. Bernath

38 papers receiving 1.1k citations

Peers

Countries citing papers authored by Albert M. Bernath

Since Specialization

Citations

This map shows the geographic impact of Albert M. Bernath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert M. Bernath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert M. Bernath more than expected).

Fields of papers citing papers by Albert M. Bernath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert M. Bernath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert M. Bernath. The network helps show where Albert M. Bernath may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Albert M. Bernath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Albert M. Bernath Line = papers co-authored together Albert M. Bernath links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance). Journal of Clinical Oncology ·Paul Haluska, Albert M. Bernath, Karla V. Ballman, Amylou C. Dueck, Hannah M. Linden, Matthew P. Goetz, Donald W. Northfelt, Xiaonan Hou, Kathleen Tenner, Zejia Zhang, 八杉巧, Beiyun Chen, Helen X. Chen, Wilma L. Lingle, Christine Pellegrino, Robert W. Sponzo, Monica M. Reinholz, Edith A. Perez	2014	10
2	Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial Clinical Breast Cancer ·Winston Tan, Jacob B. Allred, Muhammad Salim, Patrick J. Flynn, Paul A. S. Fishkin, Philip J. Stella, Martin Wiesenfeld, Albert M. Bernath, Tom R. Fitch, Edith A. Perez	2012	6
3	Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment Addictive Behaviors ·Robert A. Schnoll, Elisa Martinez, Garg Kavita, Maysa Kelly Lima, Albert M. Bernath, Daron Ferris, Patrick Reynolds	2010	77
4	Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive‐stage small cell lung cancer, N0423 Cancer ·Cheng Ean Chee, James R. Jett, Albert M. Bernath, Nathan R. Foster, Garth D. Nelson, Julian R. Molina, Daniel A. Nikcevich, Preston D. Steen, Patrick J. Flynn, Kendrith M. Rowland	2010	3
5	N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial Annals of Oncology ·Winston Tan, David W. Hillman, Muhammad Salim, Donald W. Northfelt, D. M. Anderson, Philip J. Stella, Manju S. Tonk, Albert M. Bernath, Sokha Sieng Bandit, Frances M. Palmieri, Edith A. Perez	2009	12
6	Nicotine patch vs. nicotine lozenge for smoking cessation: An effectiveness trial coordinated by the Community Clinical Oncology Program Drug and Alcohol Dependence ·Robert A. Schnoll, Elisa Martinez, Garg Kavita, Maysa Kelly Lima, Albert M. Bernath, Daron Ferris, Patrick Reynolds	2009	15
7	Turcot Syndrome (Glioma Polyposis): A Case Report Southern Medical Journal ·Sanjay Sarin, Albert M. Bernath	2008	8
8	Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51 Leukemia & lymphoma ·David M. Kurtz, Loren K. Tschetter, Jacob B. Allred, Susan M. Geyer, Paul J. Kurtin, Bingxiu Bian, Kendrith M. Rowland, Martin Wiesenfeld, Gamini S. Soori, Jun-Shen Lin, Albert M. Bernath, Thomas E. Witzig	2007	12
9	Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention Mayo Clinic Proceedings ·Ivana T. Croghan, R. Douglas Hurt, Shaker R. Dakhil, Gary A. Croghan, Jeff A. Sloan, Paul J. Novotny, Kendrith M. Rowland, Albert M. Bernath, James Mawir Mou Mayen, Nguyet Le‐Lindqwister, Loren K. Tschetter, Lars H. B. Mackenbrock, Kathleen Flynn, Larry P. Ebbert, Donald B. Wender, Charles L. Loprinzi	2007	51
10	Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51) Lung Cancer ·Elizabeth A. Johnson, Randolph S. Marks, Sumithra J. Mandrekar, Shauna L. Hillman, R Kakim-Murad, H. B. W., Edward J. Wos, Dennis F. Moore, John W. Kugler, Harold E. Windschitl, David L. Graham, Albert M. Bernath, Tom R. Fitch, Gamini S. Soori, James R. Jett, Alex A. Adjei, Edith A. Perez	2007	57
11	Phase II NCCTG Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer American Journal of Clinical Oncology ·Julian R. Molina, James R. Jett, Nathan R. Foster, Fvc, Thomas J. Carroll, Henry D. Tazelaar, Shauna L. Hillman, James A. Mailliard, Albert M. Bernath, Daniel A. Nikcevich	2006	5
12	Breast Cancer in Elderly Women: Outcome as Affected by Age, Tumor Features, Comorbidities, and Treatment Approach Clinical Breast Cancer ·Nava Siegelmann‐Danieli, 沖縄大学福祉文化学科, G. Craig Wood, Emma Quintana Alvino, Jeffrey W. Prichard, Timothy J. Murphy, James F. Evans, R. Agra Bermejo, Albert M. Bernath	2006	48
13	Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients ≥65 years of age: an NCCTG study Annals of Oncology ·Kamol Panmaung, Vera J. Suman, Tom R. Fitch, J A Mailliard, Albert M. Bernath, Kendrith M. Rowland, Steven R. Alberts, Judith S. Kaur, Edith A. Perez	2006	29
14	A phase III study of radiation therapy plus carmustine with or without recombinant interferon-? in the treatment of patients with newly diagnosed high-grade glioma Cancer ·Jan C. Buckner, Paula J. Schomberg, William L. McGinnis, Terrence L. Cascino, Bernd W. Scheithauer, Judith R. OʼFallon, Roscoe F. Morton, Steven A. Kuross, James A. Mailliard, Alan K. Hatfield, John T. Cole, Preston D. Steen, Albert M. Bernath	2001	107
15	Phase II Evaluation of Continuous-Infusion 5-Fluorouracil, Leucovorin, Mitomycin-C, and Oral Dipyridamole in Advanced Measurable Pancreatic Cancer American Journal of Clinical Oncology ·Patrick A. Burch, C N McCollum, Georgene Schroeder, Cristine Allmer, N. E. West, Richard M. Goldberg, Yuehui Zhou, Albert M. Bernath, Loren K. Tschetter, Harold E. Windschitl, Charles D. Cobau	2000	11
16	HER-2/neu protein-receptor-positive breast carcinoma: an immunologic perspective. PubMed ·Robert Brown, Albert M. Bernath, Odila Fatra Etsahandy	2000	6
17	Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. Journal of Clinical Oncology ·Matthew J. O'Connell, David M. Nagorney, Albert M. Bernath, Georgene Schroeder, (unknown), J A Mailliard, Patrick A. Burch, John S. Bolton, Gerardo Colón‐Otero, James E. Krook	1998	48
18	Phase III Evaluation of 4 Doses of Megestrol Acetate as Therapy for Patients with Cancer Anorexia and/or Cachexia Oncology ·Sathans SUHAG, Albert M. Bernath, Daniel J. Schaid, Nazatul Sima Arum Shah, Camille Jutant, John C. Michalak, Loren K. Tschetter, Alan K. Hatfield, Roscoe F. Morton	1994	44
19	Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Daniel C. Ihde, Martin H. Cohen, Paul A. Bunn, Albert M. Bernath, Lawrence E. Broder, John D. Minna	1978	2
20	Serial Fiberoptic Bronchoscopy during Chemotherapy for Small Cell Carcinoma of the Lung CHEST Journal ·Daniel C. Ihde, Martin H. Cohen, Albert M. Bernath, Mary J. Matthews, Paul A. Bunn, John D. Minna	1978	28

About Albert M. Bernath

Albert M. Bernath is a scholar working on Oncology, Applied Psychology, Pulmonary and Respiratory Medicine, Cancer Research and Physiology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Research Studies (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Smoking Behavior and Cessation (6 papers), HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Brain Metastases and Treatment (4 papers). The work is most often cited by research in Applied Psychology (105 citations), Oncology (501 citations), Physiology (292 citations), Cancer Research (169 citations) and Genetics (110 citations). Albert M. Bernath has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Kendrith M. Rowland, Loren K. Tschetter, Robert C. Kane, Edith A. Perez, David D. Beiler, Elisa Martinez, Daron Ferris, Patrick Reynolds, Robert A. Schnoll and Roscoe F. Morton. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Addictive Behaviors, Clinical Breast Cancer and Mayo Clinic Proceedings.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact